Retreatment with 90Y-labelled ibritumomab tiuxetan in a patient with follicular lymphoma who had previously responded to treatment

Lancet Oncol. 2007 Sep;8(9):849-50. doi: 10.1016/S1470-2045(07)70277-2.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Antibodies, Monoclonal / therapeutic use*
  • Humans
  • Lymphoma, Follicular / radiotherapy*
  • Male
  • Neoplasm Recurrence, Local / radiotherapy
  • Radioimmunotherapy
  • Retreatment
  • Yttrium Radioisotopes / therapeutic use

Substances

  • Antibodies, Monoclonal
  • Yttrium Radioisotopes
  • ibritumomab tiuxetan